TWI325323B - Cross-linked glycopeptide-cephalosporin antibiotics - Google Patents

Cross-linked glycopeptide-cephalosporin antibiotics Download PDF

Info

Publication number
TWI325323B
TWI325323B TW092114010A TW92114010A TWI325323B TW I325323 B TWI325323 B TW I325323B TW 092114010 A TW092114010 A TW 092114010A TW 92114010 A TW92114010 A TW 92114010A TW I325323 B TWI325323 B TW I325323B
Authority
TW
Taiwan
Prior art keywords
group
alkyl
hydrogen
independently selected
compound
Prior art date
Application number
TW092114010A
Other languages
English (en)
Chinese (zh)
Other versions
TW200307556A (en
Inventor
Marquess Daniel
S Linsell Martin
Derek Turner S
G Trapp Sean
D Long Daniel
Fatheree Paul
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of TW200307556A publication Critical patent/TW200307556A/zh
Application granted granted Critical
Publication of TWI325323B publication Critical patent/TWI325323B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
TW092114010A 2002-05-24 2003-05-23 Cross-linked glycopeptide-cephalosporin antibiotics TWI325323B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38327402P 2002-05-24 2002-05-24

Publications (2)

Publication Number Publication Date
TW200307556A TW200307556A (en) 2003-12-16
TWI325323B true TWI325323B (en) 2010-06-01

Family

ID=29584538

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092114010A TWI325323B (en) 2002-05-24 2003-05-23 Cross-linked glycopeptide-cephalosporin antibiotics

Country Status (8)

Country Link
US (4) US6878686B2 (https=)
EP (1) EP1507796B1 (https=)
JP (2) JP4347799B2 (https=)
AT (1) ATE556088T1 (https=)
AU (1) AU2003231833A1 (https=)
ES (1) ES2384707T3 (https=)
TW (1) TWI325323B (https=)
WO (1) WO2003099858A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1140993E (pt) * 1998-12-23 2003-10-31 Theravance Inc Derivados de glicopeptidos e composicoes farmaceuticas contendo os mesmos
TWI335332B (en) * 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
TWI325323B (en) * 2002-05-24 2010-06-01 Theravance Inc Cross-linked glycopeptide-cephalosporin antibiotics
JP2007500222A (ja) 2003-05-23 2007-01-11 セラヴァンス インコーポレーテッド 架橋グリコペプチド−セファロスポリン抗生物質
DE602004012269T2 (de) * 2003-07-11 2009-04-30 Theravance, Inc., South San Francisco Quervernetzte glycopeptid-cephalosporin-antibiotika
US20080020961A1 (en) * 2006-07-21 2008-01-24 Rodrigues Klin A Low Molecular Weight Graft Copolymers
EP2435464B1 (en) * 2009-05-29 2014-07-16 Covalx AG Cross-linking reagents for molecular interaction analysis
WO2012129493A1 (en) * 2011-03-24 2012-09-27 Seachaid Pharmaceuticals, Inc. Vancomycin derivatives
MX352760B (es) 2011-09-09 2017-12-07 Merck Sharp & Dohme Corp Star Metodos para tratar infecciones intrapulmonares.
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
EP2970164B1 (en) 2013-03-13 2017-05-03 Theravance Biopharma Antibiotics IP, LLC Crystalline form of a substituted thiazolylacetic acid triethylamine salt
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
DK2893929T3 (da) 2013-03-15 2025-07-07 Merck Sharp & Dohme Llc Antibiotisk ceftolozansammensætninger
KR102237887B1 (ko) 2013-03-15 2021-04-07 멜린타 서브시디어리 코프. 항생제를 사용하여 과체중 및 비만 환자에서 감염을 치료하는 방법
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
US11878958B2 (en) 2022-05-25 2024-01-23 Ikena Oncology, Inc. MEK inhibitors and uses thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693A (en) 1848-08-01 Window-catch
US7A (en) 1836-08-10 Thomas Blanchard Machine for boring holes and cutting lanyard-scores in deadeyes
US947926A (en) * 1908-09-15 1910-02-01 William C Meyer Expansion-reamer.
GB2033377B (en) 1978-09-11 1983-05-05 Fujisawa Pharmaceuticalco Ltd Cephem compounds and processes for preparation thereof
US4341775A (en) 1978-09-11 1982-07-27 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4220761A (en) 1978-09-12 1980-09-02 Fujisawa Pharmaceutical Co., Ltd. 7-[Substituted oximinoacetamido]-3-[hydroxy alkyltetrazolo]cephalosporin derivatives
JPS6041682A (ja) 1983-08-16 1985-03-05 Meiji Seika Kaisha Ltd 新規セフアロスポリン化合物及びその製造法
US4921851A (en) 1986-06-09 1990-05-01 Takeda Chemical Industries, Ltd. Cephem compounds, their production and use
AU1630988A (en) 1987-05-30 1988-12-01 Kyoto Pharmaceutical Industries, Ltd. Cephalosporin compound and pharmaceutical composition thereof
US5693791A (en) 1995-04-11 1997-12-02 Truett; William L. Antibiotics and process for preparation
CA2318394A1 (en) 1998-02-20 1999-08-26 Advanced Medicine, Inc. Novel antibacterial agents
US6437119B1 (en) 1998-05-07 2002-08-20 William Lawrence Truett Compounds formed from two or three antibiotics and their processes of preparation
US6288234B1 (en) 1998-06-08 2001-09-11 Advanced Medicine, Inc. Multibinding inhibitors of microsomal triglyceride transferase protein
US7208572B2 (en) * 1998-08-21 2007-04-24 Albany Medical College Leptin-related peptides
PT1140993E (pt) 1998-12-23 2003-10-31 Theravance Inc Derivados de glicopeptidos e composicoes farmaceuticas contendo os mesmos
AU2001238020A1 (en) * 2000-02-04 2001-08-14 Advanced Medicine, Inc. Glycopeptide derivatives having antibiotic activity
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
US20030008812A1 (en) * 2001-02-02 2003-01-09 Christensen Burton G. Glycopeptide derivatives
TWI335332B (en) 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
TWI325323B (en) * 2002-05-24 2010-06-01 Theravance Inc Cross-linked glycopeptide-cephalosporin antibiotics
JP2007500222A (ja) 2003-05-23 2007-01-11 セラヴァンス インコーポレーテッド 架橋グリコペプチド−セファロスポリン抗生物質
US7127856B2 (en) * 2003-06-06 2006-10-31 Hans T. Hagen, Jr. Insulated stud panel and method of making such
DE602004012269T2 (de) 2003-07-11 2009-04-30 Theravance, Inc., South San Francisco Quervernetzte glycopeptid-cephalosporin-antibiotika

Also Published As

Publication number Publication date
US20060025332A1 (en) 2006-02-02
US6995138B2 (en) 2006-02-07
ATE556088T1 (de) 2012-05-15
ES2384707T3 (es) 2012-07-11
US6878686B2 (en) 2005-04-12
US20050209132A1 (en) 2005-09-22
AU2003231833A1 (en) 2003-12-12
US8084417B2 (en) 2011-12-27
JP2009256358A (ja) 2009-11-05
EP1507796B1 (en) 2012-05-02
TW200307556A (en) 2003-12-16
US20040033939A1 (en) 2004-02-19
EP1507796A1 (en) 2005-02-23
US20090137460A1 (en) 2009-05-28
JP2006503805A (ja) 2006-02-02
US7405199B2 (en) 2008-07-29
JP4347799B2 (ja) 2009-10-21
WO2003099858A1 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
TWI325323B (en) Cross-linked glycopeptide-cephalosporin antibiotics
TWI335332B (en) Cross-linked vancomycin-cephalosporin antibiotics
JP4555823B2 (ja) 架橋されたグリコペプチド−セファロスポリン抗生物質
JP2010537997A (ja) 二機能性ポリマーに結合させたインフルエンザウイルス阻害剤
JP2010254701A (ja) 架橋グリコペプチド−セファロスポリン抗生物質
TW201032817A (en) Compounds
JP6254525B2 (ja) バンコマイシン耐性菌株に対して有効なグリコペプチド系抗生物質類似体
CN106687140A (zh) 半胱胺在治疗由酵母菌/霉菌引起的感染中的用途
JP2013521330A (ja) 抗菌剤として有用なペプチド化合物
CN112739710B (zh) 具有抗菌特性的化合物
CN103974713B (zh) 用于治疗感染性疾病的抗微生物肽
CN102827288B (zh) 一种酸激活csp靶向抗菌肽及其制备和应用
WO2019170046A1 (zh) 一组具有抗耐药性细菌活性的糖肽类化合物、其制备方法和应用
US8507427B2 (en) Structural and mechanistic basis for novel compound biosynthesis using the 4-electron hexose oxidase
TW200417548A (en) Beta-lactamase inhibitor prodrug
JP2020172441A (ja) シデロフォア型抗菌用医薬組成物
WO2014161412A1 (zh) 一类三环喹诺酮衍生物及其制备方法和用途
CN108727332A (zh) 一种丙烯栓系环丙沙星-吲哚满二酮杂化物及其合成方法和用途
WO2004094370A2 (en) Antibacterial pyrazole carboxylic acid hydrazides
CN117142940B (zh) 抗菌苯醌类衍生物、制备方法及应用
KR101893005B1 (ko) 신규한 루파리엘롤라이드의 피리다진온 유도체 화합물 및 이를 유효성분으로 포함하는 항균용 조성물
JP4058511B2 (ja) ステロイド誘導体を主成分とする抗菌剤
US20260092083A1 (en) Vancomycin derivatives with siderophore modification as novel repurposed antibiotics to combat gram-negative bacterial infection
KR20250100196A (ko) 신규한　루파리엘롤라이드의 피리다진온 유도체 화합물 및 이를 유효성분으로 포함하는 항균용 조성물
JP2014503578A (ja) Ｍｄｒポンプ阻害活性を有する新規なアザクマリン誘導体

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees